Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials Article (Faculty180)

cited authors

  • Mousavi, Asma; Shojaei, Shayan; Soleimani, Hamidreza; Semirani-Nezhad, Davood; Ebrahimi, Pouya; Zafari, Ali; Ebrahimi, Rasoul; Roozbehi, Khatere; Harrison, Anil; Syed, Mushabbar A; Kuno, Toshiki; Askari, Mani Khorsan K; Almandoz, Jaime P; Jun, John; Hosseini, Kaveh

authors

publication date

  • 2025

published in

start page

  • 68

volume

  • 17